Kind Consumer

📍 London, United Kingdom🗓 Founded 2006👥 7 employees💰 Last funded Jul 2018
Kind Consumer is a healthcare research and development company specialising in respiratory drug delivery and tobacco harm reduction. An example of our innovative work is Voke*, a next generation nicotine inhaler launching later this year and licensed by the Department of Health. With revolutionary valve technology it provides rapid nicotine absorption and craving relief. Headquartered in London, we at Kind Consumer believe that significant progress can be made through new technologies and scientific breakthroughs to improve public health. In order to achieve this, Kind works with a range of stakeholders, organisations and regulators to make sure our products are thoroughly assessed for quality, safety and efficacy. *Voke 0.45mg Inhaler contains nicotine and can be used to reduce, replace or stop smoking. Requires willpower. Always read the leaflet.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Kind Consumer?
Kind Consumer has 1 investors on record on gritt.io.
When did Kind Consumer last raise funding?
The most recent investment in Kind Consumer recorded on gritt.io was in July 2018.
When was Kind Consumer founded?
Kind Consumer was founded in 2006.
What industry is Kind Consumer in?
Kind Consumer operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Kind Consumer based?
Kind Consumer is headquartered in London, United Kingdom.